Qiagen Gelecekteki Büyüme
Future kriter kontrolleri 4/6
Qiagen is forecast to grow earnings and revenue by 34.3% and 7% per annum respectively. EPS is expected to grow by 33.4% per annum. Return on equity is forecast to be 12.5% in 3 years.
Anahtar bilgiler
34.3%
Kazanç büyüme oranı
33.4%
EPS büyüme oranı
Life Sciences kazanç büyümesi | 26.4% |
Gelir büyüme oranı | 7.0% |
Gelecekteki özkaynak getirisi | 12.5% |
Analist kapsamı | Good |
Son güncelleme | 17 Oct 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | 2,233 | 501 | 523 | 774 | 15 |
12/31/2025 | 2,090 | 436 | 447 | 613 | 20 |
12/31/2024 | 1,974 | 209 | 298 | 503 | 19 |
6/30/2024 | 1,940 | 73 | 405 | 576 | N/A |
3/31/2024 | 1,939 | 337 | 358 | 521 | N/A |
12/31/2023 | 1,965 | 341 | 297 | 459 | N/A |
9/30/2023 | 1,956 | 485 | 302 | 468 | N/A |
6/30/2023 | 1,978 | 337 | 376 | 519 | N/A |
3/31/2023 | 1,999 | 353 | 430 | 580 | N/A |
12/31/2022 | 2,142 | 423 | 566 | 715 | N/A |
9/30/2022 | 2,226 | 488 | 660 | 826 | N/A |
6/30/2022 | 2,261 | 539 | 580 | 770 | N/A |
3/31/2022 | 2,313 | 563 | 556 | 755 | N/A |
12/31/2021 | 2,252 | 513 | 432 | 639 | N/A |
9/30/2021 | 2,240 | 311 | 516 | 745 | N/A |
6/30/2021 | 2,190 | 480 | 337 | 592 | N/A |
3/31/2021 | 2,065 | 449 | 239 | 571 | N/A |
12/31/2020 | 1,870 | 359 | 154 | 458 | N/A |
9/30/2020 | 1,713 | 191 | 10 | 298 | N/A |
6/30/2020 | 1,612 | 14 | 108 | 333 | N/A |
3/31/2020 | 1,550 | -31 | 152 | 302 | N/A |
12/31/2019 | 1,526 | -41 | 56 | 331 | N/A |
9/30/2019 | 1,516 | -25 | 60 | 332 | N/A |
6/30/2019 | 1,511 | 196 | 58 | 342 | N/A |
3/31/2019 | 1,507 | 188 | 87 | 356 | N/A |
12/31/2018 | 1,502 | 190 | 209 | 359 | N/A |
9/30/2018 | 1,496 | 90 | 189 | 325 | N/A |
6/30/2018 | 1,482 | 78 | 189 | 324 | N/A |
3/31/2018 | 1,453 | 55 | N/A | 275 | N/A |
12/31/2017 | 1,418 | 40 | N/A | 287 | N/A |
9/30/2017 | 1,387 | 89 | N/A | 311 | N/A |
6/30/2017 | 1,362 | 75 | N/A | 323 | N/A |
3/31/2017 | 1,347 | 82 | N/A | 353 | N/A |
12/31/2016 | 1,338 | 80 | N/A | 342 | N/A |
9/30/2016 | 1,320 | 123 | N/A | 328 | N/A |
6/30/2016 | 1,296 | 123 | N/A | 331 | N/A |
3/31/2016 | 1,281 | 126 | N/A | 303 | N/A |
12/31/2015 | 1,281 | 130 | N/A | 317 | N/A |
9/30/2015 | 1,293 | 104 | N/A | 310 | N/A |
6/30/2015 | 1,315 | 105 | N/A | 303 | N/A |
3/31/2015 | 1,326 | 113 | N/A | 305 | N/A |
12/31/2014 | 1,345 | 116 | N/A | 288 | N/A |
9/30/2014 | 1,345 | 151 | N/A | 291 | N/A |
6/30/2014 | 1,331 | 157 | N/A | 284 | N/A |
3/31/2014 | 1,315 | 72 | N/A | 259 | N/A |
12/31/2013 | 1,302 | 69 | N/A | 259 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: 1QGEN's forecast earnings growth (34.3% per year) is above the savings rate (2.4%).
Kazançlar ve Piyasa: 1QGEN's earnings (34.3% per year) are forecast to grow faster than the Italian market (7.3% per year).
Yüksek Büyüme Kazançları: 1QGEN's earnings are expected to grow significantly over the next 3 years.
Gelir ve Pazar: 1QGEN's revenue (7% per year) is forecast to grow faster than the Italian market (3.9% per year).
Yüksek Büyüme Geliri: 1QGEN's revenue (7% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: 1QGEN's Return on Equity is forecast to be low in 3 years time (12.5%).